These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31153054)

  • 1. Rab7b participation on the TLR4 (Toll-like receptor) endocytic pathway in Shiga toxin-associated Hemolytic Uremic Syndrome (HUS).
    Lafalla Manzano AF; Gil Lorenzo AF; Bocanegra V; Costantino VV; Cacciamani V; Benardon ME; Vallés PG
    Cytokine; 2019 Sep; 121():154732. PubMed ID: 31153054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.
    Vallés PG; Melechuck S; González A; Manucha W; Bocanegra V; Vallés R
    Pediatr Nephrol; 2012 Mar; 27(3):407-15. PubMed ID: 21969092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4.
    Wang Y; Chen T; Han C; He D; Liu H; An H; Cai Z; Cao X
    Blood; 2007 Aug; 110(3):962-71. PubMed ID: 17395780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production is altered in monocytes from children with hemolytic uremic syndrome.
    Fernández GC; Ramos MV; Landoni VI; Bentancor LV; Fernández-Brando RJ; Exeni R; Laso Mdel C; Exeni A; Grimoldi I; Isturiz MA; Palermo MS
    J Clin Immunol; 2012 Jun; 32(3):622-31. PubMed ID: 22228570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
    Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
    Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Ohara S; Sato M; Hosoya M
    Nephrol Dial Transplant; 2015 Jun; 30(6):969-77. PubMed ID: 25694534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
    Ståhl AL; Sartz L; Nelsson A; Békássy ZD; Karpman D
    PLoS One; 2009 Sep; 4(9):e6990. PubMed ID: 19750223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
    Karpman D; Papadopoulou D; Nilsson K; Sjögren AC; Mikaelsson C; Lethagen S
    Blood; 2001 May; 97(10):3100-8. PubMed ID: 11342436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.
    Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S
    Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rab7b, a novel lysosome-associated small GTPase, is involved in monocytic differentiation of human acute promyelocytic leukemia cells.
    Yang M; Chen T; Han C; Li N; Wan T; Cao X
    Biochem Biophys Res Commun; 2004 Jun; 318(3):792-9. PubMed ID: 15144907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvesicle Involvement in Shiga Toxin-Associated Infection.
    Villysson A; Tontanahal A; Karpman D
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29156596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes.
    Ramos MV; Ruggieri M; Panek AC; Mejias MP; Fernandez-Brando RJ; Abrey-Recalde MJ; Exeni A; Barilari C; Exeni R; Palermo MS
    Clin Sci (Lond); 2015 Aug; 129(3):235-44. PubMed ID: 25748554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.
    McCarthy TA; Barrett NL; Hadler JL; Salsbury B; Howard RT; Dingman DW; Brinkman CD; Bibb WF; Cartter ML
    Pediatrics; 2001 Oct; 108(4):E59. PubMed ID: 11581467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab7b Overexpression-Ameliorated Ischemic Brain Damage Following tMCAO Involves Suppression of TLR4 and NF-κB p65.
    Qi J; Rong Y; Wang L; Xu J; Zhao K
    J Mol Neurosci; 2019 Jun; 68(2):163-170. PubMed ID: 30911939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients.
    Ando M; Shibuya A; Tsuchiya K; Akiba T; Nitta K
    Kidney Int; 2006 Jul; 70(2):358-62. PubMed ID: 16738534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
    Slusher AL; Zúñiga TM; Acevedo EO
    Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.
    Pahwa R; Devaraj S; Jialal I
    Int J Obes (Lond); 2016 Jun; 40(6):907-11. PubMed ID: 26880233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.